Rishi Gupta

Rishi Gupta is a Partner at OrbiMed. Prior to that, he was a healthcare investment banker at Raymond James & Associates, served as manager of corporate development at Veritas Medicine, and was a summer associate at Wachtell, Lipton, Rosen & Katz. In addition to Pionyr, Rishi serves or has served on the boards of Turnstone Biologics, EnLiven Therapeutics, NeuroPace, Verona Pharma, Avitide, Modis Therapeutics, Symbiomix Therapeutics, Dimension Therapeutics, ChemoCentryx, and Sientra. He has also been actively involved with OrbiMed’s investments in Acceleron Pharma, CoGenesys, Supernus Pharmaceuticals, Adimab, Receptos, Aragon Pharmaceuticals, Seragon Pharmaceuticals, Alector, Arsanis, Biotie, Invitae, and ORIC Pharmaceuticals. Rishi earned a J.D. from Yale Law School and an A.B. degree magna cum laude in biochemical sciences from Harvard College.